163 related articles for article (PubMed ID: 8235707)
21. Efficacy of alpha interferon and hydroxyurea in late phase refractory myeloproliferative disease.
Litam PP; Landaw SA; Zamkoff KW
Haematologia (Budap); 1994; 26(2):87-90. PubMed ID: 7890266
[TBL] [Abstract][Full Text] [Related]
22. Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
Schultheis B; Heissig B; Pasternak G; Hörner S; Hehlmann R
Folia Biol (Praha); 2000; 46(6):251-5. PubMed ID: 11140858
[TBL] [Abstract][Full Text] [Related]
23. [Alpha-interferons in the treatment of patients with chronic myeloid leukemia].
Abdulkadyrov KM; Udal'eva VIu; Rukavitsyn OA; Bessmel'tsev SS
Vopr Onkol; 1999; 45(4):387-92. PubMed ID: 10532097
[TBL] [Abstract][Full Text] [Related]
24. [Chronic myelogenous leukemia following therapy for pineal germinoma].
Noda M; Shoda T; Takimoto Y; Okita H
Rinsho Ketsueki; 2004 Jan; 45(1):72-4. PubMed ID: 14999938
[TBL] [Abstract][Full Text] [Related]
25. [Chronic myeloid leukemia--latest aspects and practical progress in recent years].
Griesshammer M; Heimpel H
Med Klin (Munich); 1995 Sep; 90(9):527-31. PubMed ID: 7476731
[No Abstract] [Full Text] [Related]
26. Interferon-alpha and hydroxyurea in early chronic myeloid leukemia: a comparative analysis of the Italian and German chronic myeloid leukemia trials with interferon-alpha.
Hasford J; Baccarani M; Hehlmann R; Anseri H; Tura S; Zuffa E
Blood; 1996 Jun; 87(12):5384-91. PubMed ID: 8652857
[TBL] [Abstract][Full Text] [Related]
27. [Interferon in the eradication of the Philadelphia chromosome in chronic myeloid leukemia].
Arana-Trejo RM; Ovilla-Martínez R; Gómez-Morales E; Meillon-García L; Cervantes-Peredo A; González-Llaven J; Pizzuto-Chávez J; Kofman-Alfaro S
Rev Invest Clin; 1997; 49(3):209-14. PubMed ID: 9380976
[TBL] [Abstract][Full Text] [Related]
28. e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?
Colla S; Sammarelli G; Voltolini S; Crugnola M; Sebastio P; Giuliani N
Haematologica; 2004 May; 89(5):611-3. PubMed ID: 15136228
[TBL] [Abstract][Full Text] [Related]
29. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
30. Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia.
Heimpel H; Allan NC; Baccarani M; Guilhot F; Hehlmann R; Horowitz M; Kluin-Nelemans J; Schaefer U; Storb R; Thaler J
Bone Marrow Transplant; 1996 May; 17 Suppl 3():S39. PubMed ID: 8769699
[No Abstract] [Full Text] [Related]
31. [Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia].
Boqué C; Grañena A
Sangre (Barc); 1998 Apr; 43(2):155-63. PubMed ID: 9656777
[No Abstract] [Full Text] [Related]
32. [Recent progress in therapy for chronic myelogenous leukemia].
Urabe A
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1066-73. PubMed ID: 9239158
[TBL] [Abstract][Full Text] [Related]
33. [Changing concept of conventional therapy in chronic myelogenous leukemia].
Ueda R
Rinsho Ketsueki; 2000 Apr; 41(4):268-71. PubMed ID: 10846452
[No Abstract] [Full Text] [Related]
34. Prognosis and therapy in chronic myeloid leukaemia.
Mehta J; Singhal S; Mehta BC
J Assoc Physicians India; 1992 Feb; 40(2):130-1. PubMed ID: 1629126
[No Abstract] [Full Text] [Related]
35. Treatment of Ph1-positive chronic myelogenous leukemia in children: comparison between allogeneic bone marrow transplantation and conventional chemotherapy. Spanish Working Party for BMT in Children (GETMON).
Muñoz A; Bureo E; Ortega JJ; Richard C; Olivé T; Maldonado MS; Madero L; Díaz MA
Haematologica; 1998 Nov; 83(11):981-4. PubMed ID: 9864916
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment of accelerated and blastic phase of chronic myeloid leukemia with high-dose interferon alpha and hydroxyurea: a novel approach.
Jehn U; Pötscher C; Heinemann V
Leuk Lymphoma; 1995 Sep; 19(1-2):153-7. PubMed ID: 8574162
[TBL] [Abstract][Full Text] [Related]
37. [Interferon therapy for chronic myelogenous leukemia].
Shibata A; Hashimoto S
Gan To Kagaku Ryoho; 1993 Feb; 20(2):200-6. PubMed ID: 8434957
[TBL] [Abstract][Full Text] [Related]
38. [Interferon-alpha in chronic myeloid leukemia].
Hehlmann R
Fortschr Med; 1997 Mar; 115(9):30-4, 37-8. PubMed ID: 9206694
[TBL] [Abstract][Full Text] [Related]
39. [Chronic myelocytic leukemia].
Shibata A
Rinsho Ketsueki; 1989 Aug; 30(8):1190-2. PubMed ID: 2481049
[No Abstract] [Full Text] [Related]
40. [Comparative efficiency of conventional myelosuppressive chemotherapy and therapy including interferon alpha in patients with chronic myeloid leukemia].
Volkova SA; Prytkova MV; Borovkov NN
Klin Med (Mosk); 2004; 82(3):45-50. PubMed ID: 15114775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]